RVPH icon

Reviva Pharmaceuticals
RVPH

21 hedge funds and large institutions have $39.6M invested in Reviva Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$286K
2
+$226K
3
+$141K
4
UBS Group
UBS Group
Switzerland
+$12.8K

Top Sellers

1
-$1.19M
2
-$673K
3
-$98.3K
4
HIM
HGC Investment Management
Ontario, Canada
-$3K
5
PC
Periscope Capital
Ontario, Canada
-$2.07K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.21M
2
$3.9M
3
$3.83M
4
$3.43M
5
$3.33M
6
$3.02M
7
$2.5M
8
$2.02M
9
$2.01M
10
$1.81M
11
$1.55M
12
$1.22M
13
$1.12M
14
$1.08M
15
$974K
16
$562K
17
$518K
18
$259K
19
$238K
20
$24K
21
$14K
22
–